Comparison of Efficacy, Safety, and Tolerability of Neoral vs Sandimmun in De Novo Renal Transplant Patients Over 24 Months' Treatment

By Abendroth D.   Buchholz B.   Land W.   May G.   Wiesel M.   Farber L.   Korn A.   Maibucher A.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 275-276

Elsevier

Access to resources Recommend Favorite

Long-Term Experience With Sandimmun Neoral: Results in De Novo and Stable Renal Transplant Patients After 24-Month Treatment

By German Neoral Study Group   Korn A.   Farber L.   Maibucher A.   Buchholz B.   Offermann G.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2945-2947

Elsevier

Access to resources Recommend Favorite

Double lung transplantation in cystic fibrosis patients: perioperative hemodynamic-volumetric monitoring

By Della Rocca G.   Costa M.G.   Coccia C.   Pompei L.   Pugliese F.   Bufi M.   Venuta F.   Rendina E.A.   Coloni G.F.   Gasparetto A.   Cortesini R.  

Transplantation Proceedings, Vol. 32, Iss. 1, 2000-02 ,pp. : 104-108

Elsevier

Access to resources Recommend Favorite

Neoral Versus Sandimmun in Kidney-Pancreas Transplantation

By Rigotti P.   Cadrobbi R.   Baldan N.   Ferraresso M.   Di Landro D.   Marchini F.   Zaninotto G.   Palatini P.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2924-2926

Elsevier

Access to resources Recommend Favorite

An Investigation of the Pharmacokinetics, Toxicity, and Clinical Efficacy of Neoral Cyclosporin in Cystic Fibrosis Patients

By Mikhail G.   Eadon H.   Leaver N.   Rogers P.   Stephens D.   Banner N.   Khaghani A.   Yacoub M.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 599-601

Elsevier

Access to resources Recommend Favorite